159 related articles for article (PubMed ID: 34930150)
1. ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer.
Karsono R; Haryono SJ; Karsono B; Harahap WA; Pratiwi Y; Aryandono T
BMC Cancer; 2021 Dec; 21(1):1348. PubMed ID: 34930150
[TBL] [Abstract][Full Text] [Related]
2. The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
Houtsma D; de Groot S; Baak-Pablo R; Kranenbarg EM; Seynaeve CM; van de Velde CJH; Böhringer S; Kroep JR; Guchelaar H-; Gelderblom H
Sci Rep; 2021 Feb; 11(1):3249. PubMed ID: 33547330
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
Markiewicz A; Wełnicka-Jaśkiewicz M; Skokowski J; Jaśkiewicz J; Szade J; Jassem J; Zaczek AJ
PLoS One; 2013; 8(8):e72219. PubMed ID: 23951298
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women.
Al-Amri RJ; Alotibi MKH; Al-Raddadi RI; Shebli WTY; Fallatah EIY; Alhujaily AS; Mohamed HS
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3235-3240. PubMed ID: 33247680
[TBL] [Abstract][Full Text] [Related]
5. Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis.
Zhang Y; Zhang M; Yuan X; Zhang Z; Zhang P; Chao H; Jiang L; Jiang J
Med Sci Monit; 2015 Oct; 21():2986-96. PubMed ID: 26434778
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
[TBL] [Abstract][Full Text] [Related]
7. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population.
Liu Y; Liu Y; Huang X; Sui J; Mo C; Wang J; Peng Q; Deng Y; Huang L; Li S; Qin X
Infect Genet Evol; 2014 Oct; 27():69-76. PubMed ID: 25014269
[TBL] [Abstract][Full Text] [Related]
8. XbaI and PvuII polymorphisms of estrogen receptor 1 gene in females with idiopathic scoliosis: no association with occurrence or clinical form.
Janusz P; Kotwicki T; Andrusiewicz M; Kotwicka M
PLoS One; 2013; 8(10):e76806. PubMed ID: 24155906
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B.
Zhang TT; Ye J; Xia SL; Zhang YF; Su Q; Zhang ZH; Li X
Infection; 2013 Apr; 41(2):371-8. PubMed ID: 23109139
[TBL] [Abstract][Full Text] [Related]
10. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Vitale SR; Ruigrok-Ritstier K; Timmermans AM; Foekens R; Trapman-Jansen AMAC; Beaufort CM; Vigneri P; Sleijfer S; Martens JWM; Sieuwerts AM; Jansen MPHM
BMC Cancer; 2022 Feb; 22(1):165. PubMed ID: 35151276
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility.
Ramalhinho AC; Marques J; Fonseca-Moutinho JA; Breitenfeld L
Mol Biol Rep; 2013 Aug; 40(8):5093-103. PubMed ID: 23666105
[TBL] [Abstract][Full Text] [Related]
12. ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Zundelevich A; Dadiani M; Kahana-Edwin S; Itay A; Sella T; Gadot M; Cesarkas K; Farage-Barhom S; Saar EG; Eyal E; Kol N; Pavlovski A; Balint-Lahat N; Dick-Necula D; Barshack I; Kaufman B; Gal-Yam EN
Breast Cancer Res; 2020 Feb; 22(1):16. PubMed ID: 32014063
[TBL] [Abstract][Full Text] [Related]
13. Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population.
Joshi G; Pradhan S; Mittal B
Cephalalgia; 2010 Mar; 30(3):311-20. PubMed ID: 19673915
[TBL] [Abstract][Full Text] [Related]
14. Preexisting Somatic Mutations of Estrogen Receptor Alpha (
Dahlgren M; George AM; Brueffer C; Gladchuk S; Chen Y; Vallon-Christersson J; Hegardt C; Häkkinen J; Rydén L; Malmberg M; Larsson C; Gruvberger-Saal SK; Ehinger A; Loman N; Borg Å; Saal LH
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33937624
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the ERalpha germline PvuII marker in breast cancer risk.
González-Mancha R; Galán JJ; Crespo C; Iglesias Pérez L; González-Perez A; Morón FJ; Moreno Nogueira JA; Real LM; Pascual MH; Ruiz A; Royo JL
Med Sci Monit; 2008 Mar; 14(3):CR136-43. PubMed ID: 18301357
[TBL] [Abstract][Full Text] [Related]
16. The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.
Amaral S; Schroth W; Kugler S; Fritz P; Simon W; Brauch H
Breast Cancer Res Treat; 2009 Nov; 118(2):323-31. PubMed ID: 19011961
[TBL] [Abstract][Full Text] [Related]
17. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa.
Shahzad S; Khan NU; Sombal W; Shah RU; Khan AU; Iqbal A; Munir I
Mol Biol Rep; 2023 Mar; 50(3):2445-2451. PubMed ID: 36595122
[TBL] [Abstract][Full Text] [Related]
19. Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms.
Molvarec A; Nagy B; Kovács M; Walentin S; Imreh E; Rigó J; Szalay J; Füst G; Prohászka Z; Karádi I
Clin Chim Acta; 2007 May; 380(1-2):157-64. PubMed ID: 17349986
[TBL] [Abstract][Full Text] [Related]
20. Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer.
Babyshkina N; Vtorushin S; Dronova T; Patalyak S; Slonimskaya E; Kzhyshkowska J; Cherdyntseva N; Choynzonov E
Clin Exp Med; 2019 Nov; 19(4):547-556. PubMed ID: 31562548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]